MX386393B - Andrografólido para tratar formas progresivas de esclerosis múltiple. - Google Patents

Andrografólido para tratar formas progresivas de esclerosis múltiple.

Info

Publication number
MX386393B
MX386393B MX2018015208A MX2018015208A MX386393B MX 386393 B MX386393 B MX 386393B MX 2018015208 A MX2018015208 A MX 2018015208A MX 2018015208 A MX2018015208 A MX 2018015208A MX 386393 B MX386393 B MX 386393B
Authority
MX
Mexico
Prior art keywords
andrographolide
multiple sclerosis
treatment
progressive forms
progressive
Prior art date
Application number
MX2018015208A
Other languages
English (en)
Spanish (es)
Other versions
MX2018015208A (es
Inventor
Juan L Hancke
Original Assignee
Innobioscience Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innobioscience Llc filed Critical Innobioscience Llc
Publication of MX2018015208A publication Critical patent/MX2018015208A/es
Publication of MX386393B publication Critical patent/MX386393B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/19Acanthaceae (Acanthus family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2018015208A 2016-06-08 2017-06-08 Andrografólido para tratar formas progresivas de esclerosis múltiple. MX386393B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662347218P 2016-06-08 2016-06-08
PCT/US2017/036463 WO2017214346A1 (en) 2016-06-08 2017-06-08 Andrographolide treats progressive forms of multiple sclerosis

Publications (2)

Publication Number Publication Date
MX2018015208A MX2018015208A (es) 2019-09-19
MX386393B true MX386393B (es) 2025-03-18

Family

ID=60578163

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018015208A MX386393B (es) 2016-06-08 2017-06-08 Andrografólido para tratar formas progresivas de esclerosis múltiple.

Country Status (8)

Country Link
US (1) US10722492B2 (https=)
EP (1) EP3468553B1 (https=)
JP (2) JP6928963B2 (https=)
CN (1) CN109562097B (https=)
CA (1) CA3026770C (https=)
DK (1) DK3468553T3 (https=)
MX (1) MX386393B (https=)
WO (1) WO2017214346A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019126759A1 (en) * 2017-12-22 2019-06-27 Convelo Therapeutics, Inc. Compounds and methods of promoting myelination
CN109293607A (zh) * 2018-11-14 2019-02-01 株洲千金药业股份有限公司 一种具有抗炎作用的化合物及其在制备抗炎药物中的应用
CN109223770A (zh) * 2018-11-14 2019-01-18 株洲千金药业股份有限公司 一种具有镇痛作用的化合物及其在制备镇痛药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1455826A2 (en) * 2001-12-21 2004-09-15 Ilex Oncology, Inc. Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment of multiple sclerosis
CN1921872A (zh) * 2004-02-03 2007-02-28 智利南方大学 用于激活PPR-γ受体而治疗自身免疫性疾病和阿尔茨海默病的提取自穿心莲的半日花烷型二萜类组合物
US9060994B2 (en) * 2011-12-21 2015-06-23 Inno Biosciences, S.p.A. Combination therapy with interferon and andrographolides for Multiple Sclerosis

Also Published As

Publication number Publication date
EP3468553A1 (en) 2019-04-17
US20190083458A1 (en) 2019-03-21
JP2021165304A (ja) 2021-10-14
EP3468553A4 (en) 2020-02-12
CN109562097A (zh) 2019-04-02
JP2019517550A (ja) 2019-06-24
CN109562097B (zh) 2022-06-07
CA3026770A1 (en) 2017-12-14
DK3468553T3 (da) 2023-07-03
US10722492B2 (en) 2020-07-28
WO2017214346A1 (en) 2017-12-14
CA3026770C (en) 2024-05-28
JP6928963B2 (ja) 2021-09-01
EP3468553B1 (en) 2023-05-24
MX2018015208A (es) 2019-09-19

Similar Documents

Publication Publication Date Title
CY1122344T1 (el) Blautia stercosis και wexlerae για χρηση στην θεραπευτικη αγωγη φλεγμονωδων και αυτοανοσων νοσων
MX2021002322A (es) Nuevos metodos.
DOP2017000025A (es) Composiciones y métodos de uso para tratar trastornos metabólicos
BR112019005908A2 (pt) uso de combinação de anticorpo anti-pd-1 e inibidor de vegfr na preparação de fármaco para tratamento de cânceres
CR20160069A (es) Compuestos terapéuticamente activos y sus métodos de uso
MX2015003140A (es) Formulaciones de enzalutamida.
MX380252B (es) Crenezumab para usarse en el tratamiento de enfermedad de alzheimer.
PT3481846T (pt) 24-hidroxiesteroides 11-substituídos para utilização no tratamento de afeções relacionadas com nmda
GT201600027A (es) Inhibidores de rorc2 y sus métodos de uso
GT201600002A (es) Bencil-1h-pirazolo[3,4-b]piridinas y su uso
UY35693A (es) Pirazolo[1,5-a]piridin-3-carboxamidas sustituidas y su uso
SV2018005783A (es) 5,6,7,8-tetrahidro[1,2,4]triazolo[4,3-a]piridin-3(2h)-onas y 2,5,6,7-tetrahydro-3h-pyrrolo[2,1-c][1,2,4]triazol-3-ones sustituidas su uso
MX388722B (es) Compuestos para tratar el cancer de ovario.
MX2018012285A (es) Metodos de tratamiento para enfermedades colestasicas y fibroticas.
MX2023010501A (es) Profarmacos de dantroleno y metodos de su uso.
MX379359B (es) Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
CL2021002318A1 (es) Métodos de tratamiento de amiloidosis al
IL287704A (en) Use of cannabidiol in the treatment of tuberous sclerosis complex
EA201892265A1 (ru) Способы лечения офтальмологических заболеваний
CL2021001554A1 (es) Métodos para el tratamiento de discinesia en parálisis cerebral.
NI201900023A (es) 1 - arilnaftiridin-3-carboxamidas 7-sustituidas y su uso
UY37671A (es) N-ariletil-2-aminoquinolin-4-carboxamidas sustituidas y su uso
MX386393B (es) Andrografólido para tratar formas progresivas de esclerosis múltiple.
EA201791819A1 (ru) Комбинированная терапия с применением конъюгата антитела против cd19 с лекарственным средством и винкристина
MX2018002298A (es) Metodos de uso de interleucina 10 para el tratamiento de enfermedades y trastornos.